Abstract
Pupillary responses to light offer a convenient and objective way to quickly assess the functional health of the anterior afferent visual pathways. We here present the characteristics of Pupil Cycle Time (PCT) obtained with a computerized biofeedback setting in patients with retinal and optic nerve diseases. The spectral analysis of the sustained pupillary oscillations elicited over 45 seconds of passive fixation of colored displays with different spatial configurations provides relevant information that allow distinguishing patients from healthy participants with good sensitivity and specificity. PCT measures done with this method could complement the current functional examination of chronic ophthalmic diseases whose prevalence worryingly increases worldwide.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04909398
Funding Statement
The study was funded by the Fondation Voir et Entendre
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All experimental protocols were approved by an institutional committee. The protocol conformed to the Declaration of Helsinki and was approved by the French local ethic committee: Comite de Protection des Personnes Ile de France XI, Ref CPP: 18002, Code: P1705, IDRCB: 2017-A03236-47).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.